Short Interest in Nihon Kohden Co. (OTCMKTS:NHNKY) Declines By 66.7%

Nihon Kohden Co. (OTCMKTS:NHNKY - Get Free Report) was the recipient of a significant decline in short interest in the month of February. As of February 28th, there was short interest totalling 400 shares, a decline of 66.7% from the February 13th total of 1,200 shares. Based on an average daily volume of 7,000 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the shares of the company are sold short.

Nihon Kohden Stock Down 0.6 %

NHNKY stock traded down $0.09 during trading on Thursday, hitting $14.42. 3,807 shares of the company's stock traded hands, compared to its average volume of 4,415. Nihon Kohden has a 52 week low of $10.06 and a 52 week high of $20.00. The stock has a fifty day moving average price of $14.51 and a two-hundred day moving average price of $14.43. The stock has a market capitalization of $2.46 billion, a price-to-earnings ratio of 21.20 and a beta of -0.11.

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $0.30 EPS for the quarter. Nihon Kohden had a return on equity of 15.08% and a net margin of 7.71%.

Nihon Kohden Company Profile

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.